Guest Contributor

Medical Briefs

Guest Contributor
June 30, 2000

Merck Frosst invests $250 million in facility

Merck Frosst Canada & Co is investing $250 million in its Kirkland PQ facilities, including $156 million for operational and manufacturing systems and the construction of laboratories for medicinal chemistry, molecular biology and pharmaceutical R&D.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News

CHSRF funds chairs in health services and nursing research

Genome Canada lauds completion of initial sequencing of human genome

Major endowment triggers massive increase in Univ of Toronto funding for biomedical and genetic research

Health firms dominate biotech sector as increases in R&D expenditures accelerate






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.